Inspections, Compliance, Enforcement, and Criminal Investigations
Progressive Medical Inc. - Close Out Letter 8/3/12
| Public Health Service Food and Drug Administration |
Kansas City District |
Department of Health and Human Services
August 3, 2012
Mark M. Martin, President/Owner
Progressive Medical Inc.
11085 Gravois Industrial Ct.
Saint Louis, MO 63128
Dear Mr. Martin:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter KAN 2012·05 dated January 10, 2012. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustain ability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/s/
Danial S. Hutchison
Compliance Officer
